Results 141 to 150 of about 40,413 (177)

Pharmacokinetics and safety of a fixed-dose combination of pregabalin and thioctic acid in healthy volunteers: a randomized, open-label, phase 1 crossover study. [PDF]

Front Pharmacol
Zárate E, Bravo-Lamicq C, Ocampo-Gutiérrez de Velasco DA, Arias-Carrión O.   +3 more
europepmc   +1 more source

Sources of successful participant engagement in a public health research study: A focus on a Latino community. [PDF]

PLoS One
Lomeli A, Escoto AA, Reyes B, Kornher K, Beltran-Murillo K, Nuñez K, Cohen A, Burola ML, Villegas I, Flores S, Perez-Portillo A, Porras N, Torres M, Salgin L, Cain KL, Stadnick NA, Laurent LC, Rabin BA, Seifert M.   +18 more
europepmc   +1 more source

GASDERMIN D-mediated pyroptosis as a therapeutic target in TAU-dependent frontotemporal dementia mouse model. [PDF]

J Biomed Sci
Silva-Llanes I, Smith LA, Abdelkader-Guillén A, Jiménez-Villegas J, Sarrió D, Moreno-Bueno G, Lastres-Becker I.   +6 more
europepmc   +1 more source

Phenotypic and Metabolic Variations in High-Risk Clones of Multidrug-Resistant <i>Pseudomonas aeruginosa</i>. [PDF]

Microorganisms
Gutierrez SJ, Escobar Prieto JD, Vargas DA, Burchmore R, Burguess K, Correa A.   +5 more
europepmc   +1 more source

Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1^Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial. [PDF]

Lancet Neurol
Tariot PN, Lopera FS, Ríos-Romenets S, Sink KM, Giraldo-Chica M, Acosta-Baena N, Villegas G, Espinosa A, Castaño ML, Muñoz C, Ospina P, Bocanegra Y, Tirado V, Henao E, Cardona E, Luna E, Lopez H, Sánchez G, Collazos MM, Alvarez S, Aguillón D, Hu N, Clayton D, Bittner T, Schneider A, Dolton M, Poon V, Nguyen J, Thomas RG, Schneider LS, Chen K, Su Y, Alexander RC, Quiroz YT, Cai Y, Xu YR, Ostaszewski B, Selkoe DJ, Ashton NJ, Denkinger MN, Jakimovich LJ, Doody RS, Langbaum JB, Reiman EM.   +43 more
europepmc   +1 more source

MicroRNAs Let-7b-5p and miR-24-3p as Potential Therapeutic Agents Targeting Pancreatic Cancer Stem Cells. [PDF]

Int J Mol Sci
Medrano-Silva M, Salmerón-Bárcenas EG, Arechaga-Ocampo E, Villegas-Sepúlveda N, Santos-Argumedo L, Pérez-Tapia SM, Padilla-Cristerna ML, Hernández-Montes G, Hernández-Galicia G, Sánchez-Argáez AB, Briseño-Díaz P, Sánchez-Torres C, Aguilar-Rojas A, Martínez-Zayas A, Vargas M, Hernández-Rivas R.   +15 more
europepmc   +1 more source

Identification of urinary bacterial genes as biomarkers for non-invasive diagnosis of renal lupus. [PDF]

Biomark Res
Pérez-Carrasco V, Soriano-Lerma A, Guzzi C, García-Martín ML, Tello MJ, Linde-Rodríguez Á, Sánchez-Martín V, Ortiz-González M, PRECISESADS Clinical Consortium, Gutiérrez-Fernández J, Alarcón-Riquelme ME, Soriano M, Marañón C, García-Salcedo JA.   +13 more
europepmc   +1 more source

Association of Vitamin D Supplementation with Glutathione Peroxidase (GPx) Activity, Interleukine-6 (IL-6) Levels, and Anxiety and Depression Scores in Patients with Post-COVID-19 Condition. [PDF]

Int J Mol Sci
Ignacio-Mejía I, Bandala C, González-Zamora JF, Chavez-Galan L, Buendia-Roldan I, Pérez-Torres K, Rodríguez-Díaz MZ, Pacheco-Tobón DX, Quintero-Fabián S, Vargas-Hernández MA, Carrasco-Vargas H, Falfán-Valencia R, Pérez-Rubio G, Hernández-Lara KA, Gómez-Manzo S, Ortega-Cuellar D, Ignacio-Mejía F, Cárdenas-Rodríguez N.   +17 more
europepmc   +1 more source

TNF/IFN-γ Co-Signaling Induces Differential Cellular Activation in COVID-19 Patients: Implications for Patient Outcomes. [PDF]

Int J Mol Sci
Ramón-Luing LA, Martínez-Gómez LE, Martinez-Armenta C, Martínez-Nava GA, Medina-Quero K, Pérez-Rubio G, Falfán-Valencia R, Buendia-Roldan I, Flores-Gonzalez J, Ocaña-Guzmán R, Selman M, López-Reyes A, Chavez-Galan L.   +12 more
europepmc   +1 more source